BeLOVE - Berliner Langzeitbeobachtungsstudie für vaskuläre Ereignisse

ID

10

DZPG Site

Berlin/Potsdam
General Information
Status

Ongoing (II): Recruitment and data collection ongoing

Description

Cardiovascular disease (CVD) is the leading cause of death worldwide with multiple forms of organ dysfunction, comorbidities, impaired health-related quality of life as well as frailty and dependency in the elderly. The greatest contribution to increased life expectancy between 1980 and 2002 is a reduction in age-specific mortality from cardiovascular diseases. Therefore, it is still necessary to collect and analyze data on development and progression of cardiovascular diseases in order to find new predictors for vascular events. The Berlin Longterm Observation of Vascular Events (BeLOVE) study is designed as a patient-based cohort study to provide a unique scientific structure and high quality data/biomaterial resource for a variety of studies on risk factors, interactions and causal mechanisms of different forms of CVD manifestations in a high-risk population. The objective of BeLOVE is to identify novel pathophysiological cross-disease mechanisms and treatment targets that determine both short and long-term outcome of high-risk patients with acute vascular disease. In the study patients with an acute index events due to acute cerebrovascular disorder, acute coronary syndrome, or acute heart failure, together with patients without an index event but a comparably increased risk to develop a cardiovascular event (one cohort - four disease entities).

Paper

currently in review

Trial Number

DRKS00023323

Contact
PI

Prof. Dr. Matthias Endres

Further PIs

Prof. Dr. Ulf Landmesser, Prof. Dr. Tobias Pischon, Prof. Dr. Leif-Hendrik Boldt, Prof. Dr. Kai-Uwe Eckardt, Prof. Dr. Holder Gerhardt, Dr. Ulrike Grittner, Prof. Dr. Knut Mai, Prof. Dr. Dominik N. Müller

Survey Results
Is it an interventional or non-interventional study?
  • Non-interventional
Specification of study type
  • Cohort
Is it a mono- or multicentric study?

Monocentric

Is it a single or multi country study?

Single

Which country?

Germany

Who are participants?
  • Patients with specific diseases
Which diseases? (ICD-11 classification)
  • Other
Which other diseases? (ICD-11 classification)
  • Endocrine, nutritional or metabolic diseases (05)
  • Diseases of the nervous system (08)
  • Diseases of the circulatory system (11)
Recruitment setting
  • Hospital
  • Outpatient
Target sample size

8000

Obtained sample size

~3500

Start of recruitment

2017

Minimum age of participants

18

Maximum age of participants

-

Data sources for the study
  • Biological samples
  • Cognitive measurements
  • Imaging data
  • Medical records
  • Registries
  • Interview
  • Questionnaire
  • Physiological/biochemical measurements
  • Omics technology
Is it planned to share the data?

Yes, there is a plan to make data available

Additional information about data sharing

All of individual participant data collected during the study will be shared according to the consent given by participants. Data will be available beginning in 2022 with no end of data sharing. Data will be shared with researchers whose proposed use of the data has been approved by the use & access committee of the BeLOVE study which will be established in 2021. Requests and proposals should be directed to: Dr. Joachim Weber (joachim.weber@charite.de) . To gain access the requesters will need to sign an access agreement. As accompanying documents the study protocol and informed consent forms are available.

Are further follow-ups planned?

Not planned, but possible

Is there consent to re-contact participants?

Yes

Is the implementation of further study components possible?

Yes

Biobank Module
Which material did you collect?
  • Blood
  • PBMC
  • Urin
  • Saliva
  • Other
Which other material did you collect?

Stool

What type of blood collection tubes did you use?
  • Serum
  • EDTA
  • PAXgene/Tempus
  • Other
Which other type of blood collection tube did you use?

Citrate, Heparin

Which type of data did you collect from Serum?
  • clin-chem
  • Other
Which other data did you collect from Serum?

various circulating and anti-neuronal Antibodies

Which type of data did you collect from EDTA?
  • clin-chem
  • Proteomics
  • Other
Which other data did you collect from EDTA?

Metabolomics

Which data did you collect from PAXgene/Tempus?
  • Gene expression
  • Other
Which other data did you collect from PAXgene/Tempus?

GWAS, CHIP, mRNA-Seq

Which type of data did you collect from PBMC?
  • iPSC
  • Other
Which other data did you collect from PBMC?

single-cell CHIP analysis

Which type of data did you collect from urine?
  • Other
Which other data did you collect from urine?

no data collected yet, only sample storage in biobank

Which type of data did you collect from saliva?
  • Other
Which other data did you collect from saliva?

no data collected yet, only sample storage in biobank

View raw data